leadf
logo-loader
LSE:COS

Collagen Solutions PLC

Receive alerts
Market:
LSE
Market Cap:
£29.61 m
Price
6.63 GBX
Change
0.00%
52 weeks high
6.60
52 weeks low
0.70

In brief

Collagen Solutions develops, manufactures and supplies medical-grade collagen biomaterials for use in research, medical devices, and regenerative medicine. The company provides product development and contract manufacturing services, including technology transfer and regulatory support. Customers include some of the largest pharmaceutical and medical device companies in the world. A publicly traded company, Collagen Solutions is listed on the London Stock Exchange (COS) and has locations in California and New Zealand with headquarters in Glasgow, Scotland.

Snapshot

  • Regenerative medicines and biomaterials specialist
  • Lead product is surgically-placed scaffold ChondroMimetic
  • Has agreed £30.4mln takeover deal with US firm Rosen’s Diversified